These effects, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 help the principle of focusing on ACKR3 as a novel method to modulate the opioid technique, which could open up new therapeutic avenues for opioid-relevant disorders. In addition to the https://johnf714hhe7.eveowiki.com/user